Stock screenerAll disclosures →
EDGAR →
CELU
Conviction 0HealthcareScan · Mon, Aug 10, 2026CELU$0.6801-2.94%
ResistanceSupportVol 14Vol MA14 50.42K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price0.6801
Change-2.94%
Gap-2.90%
Rel volume0.01×
Avg volume42.8K
Avg $ vol30.39K
SMA 200.7311
SMA 500.7553
SMA 2001.20
Price vs 50-9.96%
Price vs 200-43.45%
MA stackbearish
50/200 cross—
Supertrenddown · 0.8549
RSI (14)44
MACD hist-0.00
MACD crossbear · 8d
Stoch %K / %D35 / 39
ADX (14)18
+DI / −DI20 / 19
RSI divergence—
MACD divergence—
ATR %+9.76%
ADR %7.90%
52w high4.15
52w low0.5979
From 52w high-83.61%
Above 52w low+13.75%
New 52w highNo
SqueezeOff
Bollinger width26.62%
%B0.24
Donchian pos32.61%
Donchian high0.8436
Donchian low0.6010
AVWAP (52w high)1.48
vs AVWAP high-53.94%
AVWAP (52w low)0.7359
vs AVWAP low-7.59%
OBV trendDown
Chaikin MF (20)-0.58
Today vs 20d0.01×
Avg vol (14d)50.41K
Avg vol (20d)42.8K
Avg $ vol (20d)30.39K
Market cap19.69M
RS 3m (vs SPY)-28.49%
RS 6m (vs SPY)-54.23%
RS line new highNo
Trend template0/8
Technical rank8.4
1 week+3.01%
1 month-8.14%
3 months-22.71%
6 months-47.68%
1 year-79.07%
YTD-43.79%
P/E-0.21
P/B-0.52
P/S0.74
P/FCF-1.47
EPS-3.59
Div yield—
ROE240.96%
ROA-85.45%
Debt/Eq-0.61
Current0.15
EV/EBITDA-0.68
Gross margin25.44%
Net margin-345.45%
Rev growth-51.03%
EPS growth-58.43%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value36.84M
Revenue5.28M
Net income-23.08M
Gross profit184K
Free cash flow-13.41M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out28.95M
Employees115
ListedMon, Jul 19, 2021
Free float7.27M
Float %25.1%
Short interest419.53K
Days to cover2.9d
Short volume33.6%
Squeeze score26 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction0 / 100
Pattern quality—
Tech rank8.4 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance0.8518
Support0.5806
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Sep 30, 2025 · quarterly.
Congress activity
Disclosed STOCK Act trades in CELU
No recent disclosed trades by Congress in CELU. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in CELU · 3 buys · 6 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Brigido Stephen Pres., Functional Regeneration · Class A Common Stock · 2026-04-13 | Tax | 268 | $343 | 2026-04-13 | 2026-04-15 |
Brigido Stephen Pres., Functional Regeneration · Class A Common Stock · 2026-04-13 | Exercise | 821 | $0 | 2026-04-13 | 2026-04-15 |
Hariri Robert J Chief Executive Officer · Restricted Stock Units · 2026-04-13 | Exercise | 3.28K | $0 | 2026-04-13 | 2026-04-15 |
Hariri Robert J Chief Executive Officer · Class A Common Stock · 2026-04-13 | Exercise | 3.28K | $0 | 2026-04-13 | 2026-04-15 |
Brigido Stephen Pres., Functional Regeneration · Restricted Stock Units · 2026-04-13 | Exercise | 821 | $0 | 2026-04-13 | 2026-04-15 |
Haines John R Senior Exec Vice President · Class A Common Stock · 2026-04-13 | Tax | 583 | $746 | 2026-04-13 | 2026-04-15 |
Haines John R Senior Exec Vice President · Class A Common Stock · 2026-04-13 | Exercise | 1.64K | $0 | 2026-04-13 | 2026-04-15 |
Haines John R Senior Exec Vice President · Restricted Stock Units · 2026-04-13 | Exercise | 1.64K | $0 | 2026-04-13 | 2026-04-15 |
Hariri Robert J Chief Executive Officer · Class A Common Stock · 2026-04-13 | Tax | 1.18K | $2K | 2026-04-13 | 2026-04-15 |
SEC filings
EDGAR filings in CELU · 7 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.